ConsumerDaily Briefs

Consumer: Thai Beverage, JD Health, J Front Retailing, Bosideng International Holdings and more

In today’s briefing:

  • Weekly Deals Digest (26 Jun) – ThaiBev’s BeerCo, Thai Life, Tianqi Lithium, Giordano, DTAC/True
  • JD Health (6618.HK) – Logic Change Due to the New Policy?
  • Subscriptions Provide Growth Model for J Front’s Daimaru-Matsuzakaya
  • Bosideng (3998 HK): Key Takeaways from Post-FY22 Result Call, Generally Optimistic

Weekly Deals Digest (26 Jun) – ThaiBev’s BeerCo, Thai Life, Tianqi Lithium, Giordano, DTAC/True

By Arun George


JD Health (6618.HK) – Logic Change Due to the New Policy?

By Xinyao (Criss) Wang

  • The exposure draft about online drug sales activities on third-party digital healthcare platforms would add uncertainties on JD Health’s business. We analyzed the potential impact and the logic behind.
  • Keeping both self-run and third-party business is the optimal option because JD Health cannot afford losing either one. The exact impact will have to wait until policy details are released.
  • As main revenue contributor, there are concerns on JD Pharmacy in terms of profitability and policy risks. Before second growth point emerges, expectation on long-term valuation expansion would be discounted.

Subscriptions Provide Growth Model for J Front’s Daimaru-Matsuzakaya

By Michael Causton

  • Subscription usage continues to rise in Japan and a new survey suggests just under 50% of teens and 20s plan to use a subscription service this year.
  • Daimaru-Matsuzakaya’s luxury and designer brand rental business has been so successful that the company had to turn away new members for a while.
  • The department store’s owner, J Front Retailing (3086 JP), sees subscriptions as a third pillar to its business in the future.

Bosideng (3998 HK): Key Takeaways from Post-FY22 Result Call, Generally Optimistic

By Osbert Tang, CFA

  • The healthy FY22 result of Bosideng International Holdings (3998 HK) showed its ability to solidify leadership position and ride through higher costs with margin expansion. 
  • Management expects double-digit profit growth for FY23 as it pursues targeted “2+13” expansion strategy and increase push for online sales. New spokespersons and flagship store will add to promotional impacts.
  • Net cash of Rmb7.8bn and strong FCF generation ability can ensure high dividend payout (FY22: 80.2%) to sustain. Premium valuation over local apparel peers is well justified. 

Before it’s here, it’s on Smartkarma